Global CAS9 Technology Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Latest Trends
Publisher : MRA | Format : PDF
Global CAS9 Technology Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
CAS9 Technology report published by MRA Research reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2023. Global CAS9 Technology market is projected to reach US$ million in 2033, increasing from US$ million in 2023, with the CAGR of % during the period of 2023 to 2033. Demand from Biotechnology & Pharmaceutical Companies and Academic & Research Institutes are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for CAS9 Technology industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, CAS9 Technology key companies include Cellecta Inc., abm Inc., GenScript, CRISPR Therapeutic, Intellia Therapeutics Inc., GE Healthcare, Takara Bio Inc., AstraZeneca and PLC, etc. Cellecta Inc., abm Inc., GenScript are top 3 players and held % share in total in 2023.
CAS9 Technology can be divided into Genome Engineering and Disease Models, etc. Genome Engineering is the mainstream product in the market, accounting for % share globally in 2023.
CAS9 Technology is widely used in various fields, such as Biotechnology & Pharmaceutical Companies and Academic & Research Institutes, etc. Biotechnology & Pharmaceutical Companies provides greatest supports to the CAS9 Technology industry development. In 2023, global % share of CAS9 Technology went into Biotechnology & Pharmaceutical Companies filed.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global CAS9 Technology market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Cellecta Inc.
abm Inc.
GenScript
CRISPR Therapeutic
Intellia Therapeutics Inc.
GE Healthcare
Takara Bio Inc.
AstraZeneca
PLC
Merck KGaA
Bio-Rad Laboratories Inc.
Danaher Corporation (Integrated DNA Technologies Inc.)
New England Biolabs
OriGene Technologies Inc.
Lonza Group
Thermo Fisher Scientific
Segment by Type
Genome Engineering
Disease Models
Biotechnology & Pharmaceutical Companies
Academic & Research Institutes
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the CAS9 Technology market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, CAS9 Technology introduction, etc. CAS9 Technology Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRA Research’s Conclusions of CAS9 Technology market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRA Research.
North America, Europe and Asia Pacific are the key regions for CAS9 Technology industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, CAS9 Technology key companies include Cellecta Inc., abm Inc., GenScript, CRISPR Therapeutic, Intellia Therapeutics Inc., GE Healthcare, Takara Bio Inc., AstraZeneca and PLC, etc. Cellecta Inc., abm Inc., GenScript are top 3 players and held % share in total in 2023.
CAS9 Technology can be divided into Genome Engineering and Disease Models, etc. Genome Engineering is the mainstream product in the market, accounting for % share globally in 2023.
CAS9 Technology is widely used in various fields, such as Biotechnology & Pharmaceutical Companies and Academic & Research Institutes, etc. Biotechnology & Pharmaceutical Companies provides greatest supports to the CAS9 Technology industry development. In 2023, global % share of CAS9 Technology went into Biotechnology & Pharmaceutical Companies filed.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global CAS9 Technology market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Cellecta Inc.
abm Inc.
GenScript
CRISPR Therapeutic
Intellia Therapeutics Inc.
GE Healthcare
Takara Bio Inc.
AstraZeneca
PLC
Merck KGaA
Bio-Rad Laboratories Inc.
Danaher Corporation (Integrated DNA Technologies Inc.)
New England Biolabs
OriGene Technologies Inc.
Lonza Group
Thermo Fisher Scientific
Segment by Type
Genome Engineering
Disease Models
Segment by Application
Biotechnology & Pharmaceutical Companies
Academic & Research Institutes
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the CAS9 Technology market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, CAS9 Technology introduction, etc. CAS9 Technology Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRA Research’s Conclusions of CAS9 Technology market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRA Research.